Sagimet Biosciences Is A Clinical Stage Biopharmaceutical Company Based In Californiafocused On Developing Innovative Therapeutics That Target Metabolic Disordersthe Company Specializes In Fatty Acid Synthasefasninhibitorswhich Aim To Address Diseases Linked To The Overproduction Of The Fatty Acid Palmitatetheir Lead Product Candidatedenifanstatis An Oral Medication Being Developed For Metabolic Dysfunction Associated Steatohepatitismashand Has Received Breakthrough Therapy Designation From The Fda In Addition To Denifanstatsagimet Is Advancing Another Fasn Inhibitortvb 3567And Is Exploring Applications For Treating Acne And Certain Cancersthe Company Has Successfully Conducted Clinical Trialsincluding The Fascinate 2 Trialwhich Yielded Positive Results For Denifanstatsagimet Has Also Partnered With Ascletis To Expand Its Development And Commercialization Efforts In Greater Chinareflecting Its Commitment To Collaboration And Growth In The Biopharmaceutical Sector
No conferences found for this company.
| Company Name | 3v Biosciences Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
